Male/female differences in neuroprotection and neuromodulation of brain dopamine

Parkinson's Disease

Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works

Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β

Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442 · see citing works

Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity

Eeden, S. K. V. D. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,746 · see citing works

Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α

Mitra, S. W., Hoskin, E., Yudkovitz, J., Pear, L., Wilkinson, H. A., Hayashi, S., Pfaff, D. W., Ogawa, S., Rohrer, S. P., Schaeffer, J. M., et al. (2003) · Endocrinology · doi:10.1210/en.2002-221069 · Cited by 856 · see citing works

Gender differences in Parkinson's disease

Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S. A., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 744 · see citing works

Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines

Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733 · see citing works

New Insights into the Mechanism of Action of Amphetamines

Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731 · see citing works

Are men at greater risk for Parkinson's disease than women?

Wooten, G. F. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020982 · Cited by 697 · see citing works

Progesterone receptors: form and function in brain

Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675 · see citing works

Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications

Brann, D. W., Dhandapani, K. M., Wakade, C. G., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 649 · see citing works

Systematic review of incidence studies of Parkinson's disease

Twelves, D., Perkins, K. S. M., & Counsell, C. E. (2002) · Movement Disorders · doi:10.1002/mds.10305 · Cited by 619 · see citing works

Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system

Brailoiu, E., Dun, S. L., Brailoiu, G. C., Mizuo, K., Sklar, L. A., Oprea, T. I., Prossnitz, E. R., & Dun, N. J. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0017 · Cited by 501 · see citing works

Prevalence of Parkinson's disease in the elderly

de Rijk, M. C., Breteler, M. M. B., Graveland, G. A., Ott, A., Grobbee, D. E., van der Meché, F. G. A., & Albert Hofman, D. (1995) · Neurology · doi:10.1212/wnl.45.12.2143 · Cited by 488 · see citing works

Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine

LaVoie, M. J., & Hastings, T. G. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 449 · see citing works

Gender differences in Parkinson's disease: Clinical characteristics and cognition

Miller, I. N., & Cronin‐Golomb, A. (2010) · Movement Disorders · doi:10.1002/mds.23388 · Cited by 405 · see citing works

The MPTP model of Parkinson's disease

Smeyne, R. J., & Jackson-Lewis, V. R. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.017 · Cited by 377 · see citing works

Non-genomic actions of estrogens and their interaction with genomic actions in the brain.

Vasudevan, N., & Pfaff, D. (2008) · Frontiers in neuroendocrinology (Print) · doi:10.1016/j.yfrne.2007.08.003 · Cited by 360 · see citing works

The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359 · see citing works

Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues

Hazell, G. G. J., Yao, S. T., Roper, J. A., Prossnitz, E. R., O’Carroll, A., & Lolait, S. J. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0066 · Cited by 358 · see citing works

Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides

do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 356 · see citing works

Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter

Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353 · see citing works

Distribution of estrogen receptor α and β in the mouse central nervous system: In vivo autoradiographic and immunocytochemical analyses

Merchenthaler, I. J., Lane, M. V., Numan, S., & Dellovade, T. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20128 · Cited by 344 · see citing works

Impact of Progestins on Estrogen-Induced Neuroprotection: Synergy by Progesterone and 19-Norprogesterone and Antagonism by Medroxyprogesterone Acetate

Nilsen, J., & Brinton, R. D. (2002) · Endocrinology · doi:10.1210/endo.143.1.8582 · Cited by 331 · see citing works

Effect of age and gender on dopamine transporter imaging with [ 123 I]FP-CIT SPET in healthy volunteers

Lavalaye, J., Booij, J., Reneman, L., Habraken, J. B. A., & van Royen, E. A. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000279 · Cited by 305 · see citing works

The effect of estrogen replacement on early Parkinson’s disease

Saunders-Pullman, R. J., Gordon-Elliott, J. S., Parides, M. K., Fahn, S., Saunders, H. R., & Bressman, S. (1999) · Neurology · doi:10.1212/wnl.52.7.1417 · Cited by 270 · see citing works

Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter

Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266 · see citing works

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

Miller, D. B., Ali, S. F., O'Callaghan, J. P., & Laws, S. C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08230.x · Cited by 263 · see citing works

Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

Staley, J. K., Krishnan‐Sarin, S., Zoghbi, S. S., Tamagnan, G. D., Fujita, M., Seibyl, J. P., Maciejewski, P. K., O’Malley, S. S., & Innis, R. B. (2001) · Synapse · doi:10.1002/syn.1084 · Cited by 245 · see citing works

Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice

Fumagalli, F., Gainetdinov, R. R., Wang, Y., Valenzano, K. J., Miller, G. W., & Caron, M. G. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02424.1999 · Cited by 241 · see citing works

Neuroprotective actions of sex steroids in Parkinson’s disease

Bourque, M., Dluzen, D. E., & Paolo, T. D. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.014 · Cited by 239 · see citing works

The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.

Bowyer, J. F., Tank, A. W., Newport, G. D., Slikker, W., Ali, S. F., & Holson, R. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11370-0 · Cited by 233 · see citing works

Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease

Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 233 · see citing works

Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry

Walker, Q. D., Rooney, M. B., Wightman, R. M., & Kuhn, C. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00500-x · Cited by 231 · see citing works

Postmenopausal Estrogen Use Affects Risk for Parkinson Disease

Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P., & Wooten, G. F. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.886 · Cited by 226 · see citing works

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study

Benedetti, M. D., Maraganore, D. M., Bower, J. H., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2001) · Movement Disorders · doi:10.1002/mds.1170 · Cited by 224 · see citing works

Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats

Zhang, J., Cai, W.-Q., Zhou, D.-S., & Su, B.-Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02460-5 · Cited by 223 · see citing works

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

Wilson, J. M., Levey, A. I., Rajput, A. H., Ang, L. C., Guttman, M., Shannak, K. S., Niznik, H. B., Hornykiewicz, O., Pifl, C., & Kish, S. J. (1996) · Neurology · doi:10.1212/wnl.47.3.718 · Cited by 222 · see citing works

Aromatase in the Brain: Not Just for Reproduction Anymore

Garcia‐Segura, L. M. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01713.x · Cited by 209 · see citing works

Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations

Tsang, K., Ho, S.-L., & Lo, S. K. (2000) · Neurology · doi:10.1212/wnl.54.12.2292 · Cited by 204 · see citing works

Sex Differences in Clinical and Genetic Determinants of Levodopa Peak-Dose Dyskinesias in Parkinson Disease

Zappia, M., Annesi, G., Nicoletti, G., Arabia, G., Annesi, F., Messina, D., Pugliese, P., Spadafora, P., Tarantino, P., Carrideo, S., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.4.601 · Cited by 202 · see citing works

Rapid Estrogen Signaling in the Brain

Raz, L., Khan, M. M., Mahesh, V. B., Vadlamudi, R. K., & Brann, D. W. (2008) · Neurosignals · doi:10.1159/000111559 · Cited by 201 · see citing works

Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons

Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 201 · see citing works

Sex and Estrous Cycle Variations of Rat Striatal Dopamine Uptake Sites

Morissette, M., & Paolo, T. D. (2008) · Neuroendocrinology · doi:10.1159/000126507 · Cited by 191 · see citing works

Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females

Murray, H. E., Pillai, A. V., McArthur, S., Razvi, N., Datla, K. P., Dexter, D. T., & Gillies, G. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00578-x · Cited by 190 · see citing works

Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

Callier, S., Morissette, M., Grandbois, M., Pélaprat, D., & Paolo, T. D. (2001) · Synapse · doi:10.1002/syn.1067 · Cited by 186 · see citing works

Gender differences in Parkinson's disease

Shulman, L. M. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80003-9 · Cited by 183 · see citing works

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease

Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R., & Leurgans, S. E. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1 · Cited by 180 · see citing works

Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice

Gainetdinov, R. R., Fumagalli, F., Wang, Y., Jones, S. R., Levey, A. I., Miller, G. W., & Caron, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051973.x · Cited by 178 · see citing works

Gender differences in Parkinson's disease.

Lyons, K. E., Hubble, J. P., Tröster, A. I., Pahwa, R., & Koller, W. C. (1998) · PubMed · Cited by 177 · see citing works

Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models

Gingerich, S., Kim, G. L., Chalmers, J. A., Koletar, M. M., Wang, X., Wang, Y., & Belsham, D. D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.076 · Cited by 171 · see citing works

Neuroprotective role of testosterone in the nervous system.

Białek, M., Zaremba, P., Borowicz, K. K., & Czuczwar, S. J. (2004) · PubMed · Cited by 170 · see citing works

Estrogen as a neuroprotectant against MPTP-Induced neurotoxicity in C57/B1 mice

Dluzen, D. E., McDermott, J. L., & Liu, B. (1996) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(96)00086-4 · Cited by 163 · see citing works

Risk of Parkinson disease in women

Ragonese, P., D’Amelio, M., Salemi, G., Aridon, P., Gammino, M., Epifanio, A., Morgante, F., & Savettieri, G. (2004) · Neurology · doi:10.1212/wnl.62.11.2010 · Cited by 158 · see citing works

Elevated Testosterone Induces Apoptosis in Neuronal Cells

Estrada, M., Varshney, A., & Ehrlich, B. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603193200 · Cited by 156 · see citing works

Gender and the Parkinson’s disease phenotype

Baba, Y., Putzke, J. D., Whaley, N. R., Wszołek, Z. K., & Uitti, R. J. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0835-7 · Cited by 148 · see citing works

Sex Differences in Neurochemical Effects of Dopaminergic Drugs in Rat Striatum

Walker, Q. D., Ray, R., & Kuhn, C. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300915 · Cited by 148 · see citing works

The Intracrine Sex Steroid Biosynthesis Pathways

Luu-The, V., & Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81010-2 · Cited by 147 · see citing works

Role of P450 Aromatase in Sex-Specific Astrocytic Cell Death

Liu, M., Hurn, P., Roselli, C., & Alkayed, N. (2005) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/sj.jcbfm.9600331 · Cited by 146 · see citing works

Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice

Grandbois, M., Morissette, M., Callier, S., & Paolo, T. D. (2000) · Neuroreport · doi:10.1097/00001756-200002070-00024 · Cited by 146 · see citing works

Acute Administration of Non-Classical Estrogen Receptor Agonists Attenuates Ischemia-Induced Hippocampal Neuron Loss in Middle-Aged Female Rats

Lebesgue, D., Traub, M., Butte-Smith, M. D., Chen, C. H., Zukin, R. S., Kelly, M. J., & Etgen, A. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008642 · Cited by 146 · see citing works

Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats

Creutz, L. M., & Kritzer, M. (2004) · The Journal of comparative neurology · doi:10.1002/cne.20229 · Cited by 144 · see citing works

Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease

Liu, L.-X., Chen, W.-F., Xie, J., & Wong, M. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.10.005 · Cited by 139 · see citing works

Effect of Chronic Estradiol and Progesterone Treatments of Ovariectomized Rats on Brain Dopamine Uptake Sites

Morissette, M., & Paolo, T. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13415.x · Cited by 135 · see citing works

Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

Sanchez, M. G. D. B., Bourque, M., Morissette, M., & Paolo, T. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00163.x · Cited by 132 · see citing works

Preservation of the substanitia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four‐year period

Quinn, N. P., Parkes, D., Janota, I., & MARSDEN, C. D. (1986) · Movement Disorders · doi:10.1002/mds.870010109 · Cited by 132 · see citing works

Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients

Blanchet, P. J., Fang, J. Y., Hyland, Κ., Arnold, L. A., Mouradian, M. M., & Chase, T. N. (1999) · Neurology · doi:10.1212/wnl.53.1.91 · Cited by 129 · see citing works

Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease

Gillies, G. E., Murray, H. E., Dexter, D. T., & McArthur, S. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.04.022 · Cited by 128 · see citing works

The Size and Distribution of Midbrain Dopaminergic Populations are Permanently Altered by Perinatal Glucocorticoid Exposure in a Sex- Region- and Time-Specific Manner

McArthur, S., McHale, E., & Gillies, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301277 · Cited by 127 · see citing works

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease

Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., McGuire, V. M., BERNSTEIN, A. L., Bloch, D. A., Leimpeter, A. D., & Nelson, L. M. (2005) · Neurology · doi:10.1212/01.wnl.0000171344.87802.94 · Cited by 125 · see citing works

Menstrual‐related fluctuations in Parkinson's disease

Quinn, N. P., & Marsden, C. D. (1986) · Movement Disorders · doi:10.1002/mds.870010112 · Cited by 125 · see citing works

Estrogen and SERM neuroprotection in animal models of Parkinson's disease

Morissette, M., Al-Sweidi, S., Callier, S., & Paolo, T. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.008 · Cited by 122 · see citing works

Viral Vector-Mediated Overexpression of Estrogen Receptor-α in Striatum Enhances the Estradiol-Induced Motor Activity in Female Rats and Estradiol-Modulated GABA Release

Schultz, K. N., von Esenwein, S. A., Hu, M., Bennett, A. L., Kennedy, R. T., Musatov, S. A., Toran‐Allerand, C. D., Kaplitt, M. G., Young, L. J., & Becker, J. B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4647-08.2009 · Cited by 122 · see citing works

Dose and Temporal Pattern of Estrogen Exposure Determines Neuroprotective Outcome in Hippocampal Neurons: Therapeutic Implications

Chen, S., Nilsen, J., & Brinton, R. D. (2006) · Endocrinology · doi:10.1210/en.2006-0495 · Cited by 121 · see citing works

Distribution and localization patterns of estrogen receptor‐β and insulin‐like growth factor‐1 receptors in neurons and glial cells of the female rat substantia nigra: Localization of ERβ and IGF‐1R in substantia nigra

Quesada, A., Romeo, H. E., & Micevych, P. E. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21358 · Cited by 118 · see citing works

Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system

García‐Segura, L. M., Arévalo, M., & Azcoitia, Í. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81014-x · Cited by 111 · see citing works

Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats

Savageau, M. M., & Beatty, W. W. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90097-6 · Cited by 110 · see citing works

Brain aromatase expression after experimental stroke: Topography and time course

Carswell, H. V. O., Dominiczak, A. F., García‐Segura, L. M., Harada, N., Hutchison, J. B., & Macrae, I. M. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.02.016 · Cited by 110 · see citing works

Inhibition of striatal dopamine transporter activity by 17β-estradiol

Disshon, K. A., Boja, J. W., & Dluzen, D. E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00008-9 · Cited by 108 · see citing works

Implication of the Phosphatidylinositol-3 Kinase/Protein Kinase B Signaling Pathway in the Neuroprotective Effect of Estradiol in the Striatum of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mice

D’Astous, M., Méndez, P., Morissette, M., García‐Segura, L. M., & Paolo, T. D. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018671 · Cited by 105 · see citing works

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients

Growdon, J. H., Kieburtz, K. D., McDermott, M., Panisset, M., Friedman, J. H., & The Parkinson Study Group* (1998) · Neurology · doi:10.1212/wnl.50.5.1327 · Cited by 103 · see citing works

Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: Persistent improvement in mobility but increased dependency: A case study

Hariz, M. I., Johansson, F., Shamsgovara, P., Johansson, E., Hariz, G., & Fagerlund, M. (2000) · Movement Disorders · doi:10.1002/1531-8257(200001)15:1 · Cited by 102 · see citing works

Sexual differences in sensitivity to methamphetamine toxicity

Wagner, G. C., Tekirian, T. L., & Cheo, C. T. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244939 · Cited by 97 · see citing works

Impact of Progestins on Estrogen-Induced Neuroprotection: Synergy by Progesterone and 19-Norprogesterone and Antagonism by Medroxyprogesterone Acetate

Nilsen, J. (2002) · Endocrinology · doi:10.1210/en.143.1.205 · Cited by 96 · see citing works

Effects of Female Sex Steroids on Parkinsonʼs Disease in Postmenopausal Women

Strijks, E., Kremer, J. A. M., & Horstink, M. W. I. M. (1999) · Clinical Neuropharmacology · doi:10.1097/00002826-199903000-00005 · Cited by 95 · see citing works

Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters

Attali, G., Weizman, A., Gil‐Ad, I., & Rehavi, M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00136-4 · Cited by 95 · see citing works

Reduced vesicular storage of dopamine exacerbates methamphetamine‐induced neurodegeneration and astrogliosis

Guillot, T. S., Shepherd, K. R., Richardson, J. R., Wang, M. Z., Li, Y., Emson, P. C., & Miller, G. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05568.x · Cited by 94 · see citing works

Multiple Pathways Transmit Neuroprotective Effects of Gonadal Steroids

Bryant, D. N., Sheldahl, L. C., Marriott, L. K., Shapiro, R. A., & Dorsa, D. M. (2006) · Endocrine · doi:10.1385/endo:29:2:199 · Cited by 94 · see citing works

Dehydroepiandrosterone (DHEA) such as 17β‐estradiol prevents MPTP‐induced dopamine depletion in mice

D’Astous, M., Morissette, M., Tanguay, B., Callier, S., & Paolo, T. D. (2002) · Synapse · doi:10.1002/syn.10145 · Cited by 93 · see citing works

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ERα agonist

D’Astous, M., Morissette, M., & Paolo, T. D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.020 · Cited by 92 · see citing works

Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat

Johansson, P., Bagge, A. L., Nyberg, F., & Fahlke, C. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00365-8 · Cited by 91 · see citing works

Repeated Estradiol Treatment Prevents MPTP-Induced Dopamine Depletion in Male Mice

Ramirez, A. D., Liu, X., & Menniti, F. S. (2003) · Neuroendocrinology · doi:10.1159/000070277 · Cited by 91 · see citing works

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

Gao, X., & Dluzen, D. E. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00014-8 · Cited by 89 · see citing works

Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice

Yu, L., & Liao, P. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070084 · Cited by 89 · see citing works

Estrogen and the development and protection of nigrostriatal dopaminergic neurons: Concerted action of a multitude of signals, protective molecules, and growth factors

Kipp, M., Karakaya, S., Pawlak, J., de Araújo, G. W., Arnold, S., & Beyer, C. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.07.001 · Cited by 87 · see citing works

Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors α and β and interactions with cyclic AMP

Maharjan, S., Serova, L. I., & Sabban, E. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03142.x · Cited by 85 · see citing works

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

Simon, K. C., Chen, H., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2009) · Movement Disorders · doi:10.1002/mds.22619 · Cited by 85 · see citing works

Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication

Tripanichkul, W., Sripanichkulchai, K., & Finkelstein, D. I. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.029 · Cited by 85 · see citing works

The anabolic‐androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain

Kindlundh, A. M. S., Lindblom, J., Bergström, L., Wikberg, J. E. S., & Nyberg, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01402.x · Cited by 84 · see citing works

Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease

Håkansson, A. S., Westberg, L., Nilsson, S., Buervenich, S., Belin, A. C., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 83 · see citing works

Parkinson's Disease in Ferrara, Italy, 1967 Through 1987

Granieri, E., Carreras, M., Casetta, I., Govoni, V., Tola, M. R., Paolino, E., Monetti, V. C., & Bastiani, P. D. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200096026 · Cited by 82 · see citing works

Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey

Thomas, T. M., Smith, Y., Levey, A. I., & Hersch, S. M. (2000) · Synapse · doi:10.1002/1098-2396(20000915)37:4 · Cited by 81 · see citing works

Influence of Oestrogenic Compounds on Monoamine Transporters in Rat Striatum

Saux, M. L., & Paolo, T. D. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01380.x · Cited by 79 · see citing works

Molecular Biology, Pharmacology and Functional Role of the Plasma Membrane Dopamine Transporter

Gainetdinov, R. R., Caron, M. G., Beaulieu, J., & Sotnikova, T. D. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706784111579 · Cited by 75 · see citing works

Effect of Interferon-τ Administration on Endometrium of Nonpregnant Ewes: A Comparison with Pregnant Ewes

Chen, Y., Green, J. A., Antoniou, E., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1310 · Cited by 75 · see citing works

Major sex differences in non-genomic estrogen actions on intracellular signaling in mouse brain in vivo

Ábrahám, I. M., & Herbison, A. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.046 · Cited by 73 · see citing works

Androgens Induce Dopaminergic Neurotoxicity via Caspase-3-Dependent Activation of Protein Kinase Cδ

Cunningham, R. L., Giuffrida, A., & Roberts, J. L. (2009) · Endocrinology · doi:10.1210/en.2009-0640 · Cited by 73 · see citing works

Pregnancy in Parkinson's disease: A review of the literature and a case report

Hagell, P., Odin, P., & Vinge, E. (1998) · Movement Disorders · doi:10.1002/mds.870130110 · Cited by 73 · see citing works

Neurosteroid Biosynthetic Pathway Changes in Substantia Nigra and Caudate Nucleus in Parkinson's Disease

Luchetti, S., Bossers, K., Frajese, G. V., & Swaab, D. F. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00396.x · Cited by 72 · see citing works

Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease

di Michele, F., Longone, P., Romeo, E., Lucchetti, S., Brusa, L., Pierantozzi, M., Bassi, A., Bernardi, G., & Stanzione, P. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0115-1 · Cited by 72 · see citing works

The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC‐12 cells

Alyea, R. A., Laurence, S. E., Kim, S. H., Katzenellenbogen, B. S., Katzenellenbogen, J. A., & Watson, C. S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05491.x · Cited by 71 · see citing works

Crossed Cerebellar Diaschisis in Acute Ischemic Stroke: A Study with Serial SPECT and MRI

Liu, Y., Karonen, J. O., Nuutinen, J., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600467 · Cited by 70 · see citing works

Testosterone modulates mesolimbic dopaminergic activity in male rats

Hernandez, L., González, L., Murzi, E., Páez, X., Gottberg, E., & Baptista, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90632-7 · Cited by 69 · see citing works

Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death

Zhang, L., Li, B. S., Zhao, W., Chang, Y. H., Ma, W., Dragan, M., Barker, J. L., Hu, Q., & Rubinow, D. R. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00130-4 · Cited by 69 · see citing works

Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice

Dluzen, D. E. (1996) · Brain Research · doi:10.1016/0006-8993(95)01566-3 · Cited by 68 · see citing works

Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system

Gajjar, T. M., Anderson, L. I., & Dluzen, D. E. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0045-3 · Cited by 65 · see citing works

Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice

Yu, L., & Liao, P. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070027 · Cited by 63 · see citing works

Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition

McArthur, S., Murray, H. E., Dhankot, A., Dexter, D. T., & Gillies, G. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04226.x · Cited by 61 · see citing works

Lack of Effect of Testosterone and Dihydrotestosterone Compared to 17β‐Oestradiol in 1‐Methyl‐4‐Phenyl‐1,2,3,6, Tetrahydropyridine‐Mice

Ekue, A., Boulanger, J., Morissette, M., & Paolo, T. D. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00833.x · Cited by 59 · see citing works

Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?

Morale, M. C., L’Episcopo, F., Tirolo, C., Giaquinta, G., Caniglia, S., Testa, N., Arcieri, P., Serra, P. A., Lupo, G., Alberghina, M., et al. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.011 · Cited by 59 · see citing works

Differential effects of estrogen and androgen on locomotor activity induced in castrated male rats by amphetamine, a novel environment, or apomorphine

Menniti, F. S., & Baum, M. J. (1981) · Brain Research · doi:10.1016/0006-8993(81)91280-4 · Cited by 58 · see citing works

Dopamine transporter function differences between male and female CD-1 mice

Bhatt, S. D., & Dluzen, D. E. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.013 · Cited by 58 · see citing works

Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERα and ERβ)

Shughrue, P. J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.009 · Cited by 58 · see citing works

Parkinson's disease and pregnancy

Golbe, L. I. (1987) · Neurology · doi:10.1212/wnl.37.7.1245 · Cited by 56 · see citing works

Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mice

Jourdain, S., Morissette, M., Morin, N., & Paolo, T. D. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01337.x · Cited by 56 · see citing works

Conservation of the developmentally regulated dendritic localization of a Purkinje cell-specific mRNA that encodes a G-protein modulator: comparison of rodent and human Pcp2(L7) gene structure and expression

Zhang, X., Zhang, H., & Oberdick, J. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00379-0 · Cited by 56 · see citing works

Association between the estrogen receptor beta gene and age of onset of Parkinson’s disease

Westberg, L., Håkansson, A., Melke, J., Shahabi, H. N., Nilsson, S., Buervenich, S., Belin, A. C., Ahlberg, J., Grundell, M., Schulhof, B., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.010 · Cited by 55 · see citing works

Tamoxifen Diminishes Methamphetamine‐Induced Striatal Dopamine Depletion in Intact Female and Male Mice

Dluzen, D. E., McDermott, J. L., & Anderson, L. I. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00675.x · Cited by 54 · see citing works

Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17β-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum

Tomás‐Camardiel, M., Sánchez-Hidalgo, M. C., del Pino, M. J. S., Navarro, A., Machado, A., & Cano, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00502-4 · Cited by 54 · see citing works

Pilot Study on the Effect of Estrogen Replacement Therapy on Brain Dopamine Transporter Availability in Healthy, Postmenopausal Women

Gardiner, S. A. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.6.621 · Cited by 54 · see citing works

The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

Gao, X., & Dluzen, D. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03221-2 · Cited by 53 · see citing works

Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat

Liu, J., Suzuki, T., Seki, T., Namba, T., Tanimura, A., & Arai, H. (2006) · Synapse · doi:10.1002/syn.20275 · Cited by 52 · see citing works

Gender differences and estrogen effects in parkin null mice

Rodríguez‐Navarro, J. A., Solano, R. M., Casarejos, M. J., Gómez, A., Perucho, J., de Yébenes, J. G., & Mena, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05569.x · Cited by 51 · see citing works

Menstrual-related changes in motoric function in women with Parkinson’s disease

Kompoliti, K., Comella, C. L., Jaglin, J. A., Leurgans, S. E., Raman, R., & Goetz, C. G. (2000) · Neurology · doi:10.1212/wnl.55.10.1572 · Cited by 51 · see citing works

Estrogen and Parkinson s disease

Kompoliti, K. (2003) · Frontiers in bioscience · doi:10.2741/1070 · Cited by 50 · see citing works

Functional alterations of the nigrostriatal dopamine system in estrogen receptor-α knockout (ERKO) mice

Küppers, E., Krust, A., Chambon, P., & Beyer, C. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.007 · Cited by 50 · see citing works

Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways

Bourque, M., Liu, B., Dluzen, D. E., & Paolo, T. D. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.12.007 · Cited by 49 · see citing works

Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity

Morissette, M., Jourdain, S., Al-Sweidi, S., Menniti, F. S., Ramirez, A. D., & Paolo, T. D. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.004 · Cited by 49 · see citing works

Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux

Alyea, R. A., & Watson, C. S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-59 · Cited by 47 · see citing works

Stereotyped behavior elicited by amphetamine in the rat: influences of the testes.

Beatty, W., Dodge, A., & Traylor, K. L. (1982) · Pharmacology, Biochemistry and Behavior · doi:10.1016/0091-3057(82)90416-6 · Cited by 46 · see citing works

Pilot Study on the Effect of Estrogen Replacement Therapy on Brain Dopamine Transporter Availability in Healthy, Postmenopausal Women

Gardiner, S. A., Morrison, M. F., Mozley, P. D., et al. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200411000-00008 · Cited by 45 · see citing works

Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women—a preliminary study

Craig, M., Cutter, W. J., Wickham, H., van Amelsvoort, T., RYMER, J. M., Whitehead, M. I., & Murphy, D. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.03.008 · Cited by 44 · see citing works

Effects of Orchidectomy on Nigro‐Striatal Dopaminergic Function: Behavioral and Physiological Evidence

Dluzen, D. E., & Ramirez, V. D. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00117.x · Cited by 43 · see citing works

Estrogens and Parkinson's disease

Session, D. R., Pearlstone, M. M., Jewelewicz, R., & Kelly, A. C. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90133-3 · Cited by 42 · see citing works

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease

Al-Sweidi, S., Morissette, M., Bourque, M., & Paolo, T. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.031 · Cited by 40 · see citing works

Expression of aromatase in the embryonic and postnatal mouse striatum

Küppers, E., & Beyer, C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00279-4 · Cited by 39 · see citing works

Estrogen and Parkinson's disease.

Horstink, M. W. I. M., Strijks, E., & Dluzen, D. E. (2003) · PubMed · Cited by 39 · see citing works

Methamphetamine–gonadal steroid hormonal interactions:

Dluzen, D. E., Anderson, L. I., & Pilati, C. F. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00187-3 · Cited by 38 · see citing works

Tamoxifen eliminates estrogen’s neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system

Dluzen, D. E., McDermott, J. L., & Anderson, L. I. (2001) · Neurotoxicity Research · doi:10.1007/bf03033268 · Cited by 38 · see citing works

Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen

Disshon, K. A., & Dluzen, D. E. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01863-6 · Cited by 38 · see citing works

Coping with menstruation: understanding the needs of women with Parkinson's disease

Tolson, D., Fleming, V. E. M., & Schartau, E. (2002) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2002.02408.x · Cited by 37 · see citing works

Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice

Lewis, C., & Dluzen, D. E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.011 · Cited by 36 · see citing works

Dose-Response Effects of Estrogen and Tamoxifen upon Methamphetamine-Induced Behavioral Responses and Neurotoxicity of the Nigrostriatal Dopaminergic System in Female Mice

Mickley, K. R., & Dluzen, D. E. (2004) · Neuroendocrinology · doi:10.1159/000079710 · Cited by 36 · see citing works

Estrogens, Dopamine and Dyskinesias

Villeneuve, A., Langlier, P., & Bédard, P. J. (1978) · Canadian Psychiatric Association Journal · doi:10.1177/070674377802300119 · Cited by 34 · see citing works

[ 123 I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication

Lavalaye, J., Knol, R. J. J., de Bruin, K. M., Reneman, L., Janssen, A. G. M., & Booij, J. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050044 · Cited by 34 · see citing works

Estrogen Actions in the Brain

Wang, L., Andersson, S., Warner, M. N., & Gustafsson, J.-Α. (2002) · Science s STKE · doi:10.1126/stke.2002.138.pe29 · Cited by 33 · see citing works

Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice

Anderson, L. I., Leipheimer, R. E., & Dluzen, D. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.033 · Cited by 32 · see citing works

DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys

Bélanger, N., Grégoire, L., Bédard, P. J., & Paolo, T. D. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.028 · Cited by 32 · see citing works

The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal or vesicular dopamine uptake in castrated rats

Chen, R., Osterhaus, G. L., McKerchar, T. L., & Fowler, S. C. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.07.018 · Cited by 31 · see citing works

Ovarian Hormones Do Not Attenuate Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice Gonadectomized at 4 Weeks Postpartum

Yu, L., Kuo, Y., Cherng, C. G., Chen, H.-H., & Hsu, C.-H. (2002) · Neuroendocrinology · doi:10.1159/000057337 · Cited by 31 · see citing works

Differential Protective Properties of Estradiol and Tamoxifen against Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity in Mice

D’Astous, M., Steinmetz, K. R. M., Dluzen, D. E., & Paolo, T. D. (2005) · Neuroendocrinology · doi:10.1159/000091206 · Cited by 30 · see citing works

Differences in reserpine-induced striatal dopamine output and content between female and male mice: Implications for sex differences in vesicular monoamine transporter 2 function

Dluzen, D. E., Bhatt, S. D., & McDermott, J. L. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.051 · Cited by 30 · see citing works

Testosterone modulation of striatal dopamine output in orchidectomized mice

Shemisa, K., Kunnathur, V., Liu, B., Salvaterra, T. J., & Dluzen, D. E. (2006) · Synapse · doi:10.1002/syn.20309 · Cited by 30 · see citing works

Hormones and Parkinson's disease

Giladi, N., & Honigman, S. (1995) · Neurology · doi:10.1212/wnl.45.5.1028-a · Cited by 27 · see citing works

Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys

Morissette, M., & Paolo, T. D. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21977 · Cited by 27 · see citing works

Dopamine Transporter as a Marker of Neuroprotection in Methamphetamine-Lesioned Mice Treated Acutely with Estradiol

D’Astous, M., Gajjar, T. M., Dluzen, D. E., & Paolo, T. D. (2004) · Neuroendocrinology · doi:10.1159/000079664 · Cited by 26 · see citing works

Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice

Ookubo, M., Yokoyama, H., Takagi, S., Kato, H., & Araki, T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.07.019 · Cited by 26 · see citing works

Pregnancy in Parkinson’s disease: case report and discussion

Robottom, B., Mullins, R. J., & Shulman, L. M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.12.1799 · Cited by 26 · see citing works

Parkinson’s Disease in Women

Rubin, S. M. (2007) · Disease-a-Month · doi:10.1016/j.disamonth.2007.02.002 · Cited by 25 · see citing works

Sex Differences in K+‐Evoked Striatal Dopamine Output from Superfused Striatal Tissue Fragments of Reserpine‐Treated CD‐1 Mice

Ji, J.-S., McDermott, J. L., & Dluzen, D. E. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01581.x · Cited by 24 · see citing works

Estradiol and Dehydroepiandrosterone Potentiate Levodopa-Induced Locomotor Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Monkeys

Bélanger, N., Grégoire, L., Bédard, P. J., & Paolo, T. D. (2003) · Endocrine · doi:10.1385/endo:21:1:97 · Cited by 23 · see citing works

Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system

Liu, B., & Dluzen, D. E. (2006) · Synapse · doi:10.1002/syn.20307 · Cited by 23 · see citing works

Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice

Moy, L. Y., Albers, D. S., & Sonsalla, P. K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00069-9 · Cited by 22 · see citing works

Synthesis and phosphorylation of androgen receptor of the mouse brain cortex and their regulation by sex steroids during aging

Thakur, M. K., Mukherjee, A., & Mukherjee, S. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007064307220 · Cited by 21 · see citing works

The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat

Dluzen, D. E. (1986) · Hormones and Behavior · doi:10.1016/0018-506x(86)90024-3 · Cited by 20 · see citing works

Case‐control study of estrogen receptor gene polymorphisms in Parkinson's disease

Maraganore, D. M., Farrer, M. J., McDonnell, S. K., Elbaz, A., Schaid, D. J., Hardy, J., & Rocca, W. A. (2001) · Movement Disorders · doi:10.1002/mds.1253 · Cited by 17 · see citing works

Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature

Satoh, N., Yonezawa, A., Tadano, T., Kisara, K., Arai, Y., & Kinemuchi, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90617-5 · Cited by 14 · see citing works

In vitro binding assays using 3H nisoxetine and 3H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex

Meyers, B. L., & Kritzer, M. F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.010 · Cited by 14 · see citing works

Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol

D’Astous, M., Morissette, M., Callier, S., & Paolo, T. D. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20412 · Cited by 14 · see citing works

Neuroprotective Effects of Bak Foong Pill in 1-Methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-Induced Parkinson's Disease Model Mice

Liu, B., Xie, J. X., Rowlands, D. K., Gou, Y., Leung, C., Chung, Y. W., & Chan, H. C. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1245 · Cited by 13 · see citing works

Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine

Kunnathur, V., Shemisa, K., Liu, B., Salvaterra, T. J., & Dluzen, D. E. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.07.001 · Cited by 13 · see citing works

Estrogen Reduces BDNF Level, but Maintains Dopaminergic Cell Density in the Striatum of MPTP Mouse Model

Tripanichkul, W., Gerdprasert, O., & Jaroensuppaperch, E.-O. (2010) · International Journal of Neuroscience · doi:10.3109/00207451003721892 · Cited by 12 · see citing works

Does estrogen receptor gene polymorphism play a role in Parkinson's disease?

Li, X.-L., Cheng, W., Li, J., Zheng, Y.-F., Guo, C., Sun, S., & Wang, L. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.09.007 · Cited by 6 · see citing works

Estrogens and Parkinson's disease

Session, D. R., Pearlstone, M. M., Jewelewicz, R., & Kelly, A. C. (1995) · Maturitas · doi:10.1016/0378-5122(95)90004-7 · Cited by 3 · see citing works

The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal or vesicular dopamine uptake in castrated rats

Chen, R. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00975-3 · Cited by 2 · see citing works

Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome

(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone

Continuing Medical Education (CME) credits

(2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80034-9

Foreword

Smeyne, R. J. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.01.001

Untitled work

Kritzer (1997) · doi:10.1002/(sici)1096-9861(19970310)379:2

Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease

Matt, S. M., & Gaskill, P. J. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09851-4 · Cited by 286 · see citing works

Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol. analysis of sex differences

Azcoitia, I., Barreto, G. E., & Garcia-Segura, L. M. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100787 · Cited by 125 · see citing works

Role of astrocytes in the neuroprotective actions of 17β-estradiol and selective estrogen receptor modulators

Acaz‐Fonseca, E., Sánchez‐González, R., Azcoitia, Í., Arévalo, M., & García‐Segura, L. M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.009 · Cited by 104 · see citing works

Estrogen actions in the nervous system

Cersosimo, M. G., & Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001776 · Cited by 68 · see citing works

Gender-Related Effects of Sex Steroids on Histamine Release and Fc<i>ε</i>RI Expression in Rat Peritoneal Mast Cells

Muñoz-Cruz, S., Mendoza-Rodríguez, Y., Nava-Castro, K. E., Yepez-Mulia, L., & Morales-Montor, J. (2015) · Journal of Immunology Research · doi:10.1155/2015/351829 · Cited by 54 · see citing works

Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease

Poirier, A.-A., Côté, M., Bourque, M., Morissette, M., Paolo, T. D., & Soulet, D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.004 · Cited by 41 · see citing works

Sex-dependent mental illnesses and mitochondria

Shimamoto, A., & Rappeneau, V. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.02.025 · Cited by 41 · see citing works

The neurotoxicity of pesticides: Implications for Parkinson's disease

Amaral, L., Martins, M., Côrte‐Real, M., Outeiro, T. F., Chaves, S. R., & Rego, A. (2025) · Chemosphere · doi:10.1016/j.chemosphere.2025.144348 · Cited by 38 · see citing works

Sex differences in the progressive model of parkinsonism induced by reserpine in rats

Bispo, J. M. M., Melo, J. E. C., de Gois, A. M., Leal, P. C., Lins, L. C. R. F., Souza, M. F., Medeiros, K. A. A. L., Ribeiro, A. M., Silva, R. H., Marchioro, M., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.041 · Cited by 31 · see citing works

Male and female cichlid fish show cognitive inhibitory control ability

Brandão, M. L., Fernandes, A. M. T. D. A., & Gonçalves‐de‐Freitas, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-52384-2 · Cited by 34 · see citing works

The impact of biological sex and sex hormones on cognition in a rat model of early, pre-motor Parkinson’s disease

Betancourt, E., Wachtel, J., Michaelos, M., Haggerty, M., Conforti, J. M., & Kritzer, M. F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.041 · Cited by 27 · see citing works

Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use

Kim, I. Y., O’Reilly, É. J., Hughes, K. C., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171175 · Cited by 21 · see citing works

Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease

Jarras, H., Bourque, M., Poirier, A.-A., Morissette, M., Coulombe, K., Paolo, T. D., & Soulet, D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12782 · Cited by 20 · see citing works

Dopaminergic modulation by quercetin: In silico and in vivo evidence using Caenorhabditis elegans as a model

Salgueiro, W. G., Soares, M. V., Martins, C. F., Paula, F. R., Rios-Anjos, R. M., Carrazoni, T., Mori, M. A., Müller, R., Aschner, M., Belo, C. A. D., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110610 · Cited by 18 · see citing works

Task-specific effects of biological sex and sex hormones on object recognition memories in a 6-hydroxydopamine-lesion model of Parkinson's disease in adult male and female rats

Pinizzotto, C. C., Patwardhan, A., Aldarondo, D., & Kritzer, M. F. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105206 · Cited by 15 · see citing works

Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons

Du, Y., Lee, Y. B., & Graves, S. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108817 · Cited by 15 · see citing works

Biological Sex and Sex Hormone Impacts on Deficits in Episodic-Like Memory in a Rat Model of Early, Pre-motor Stages of Parkinson's Disease

Conner, M. R., Jang, D., Anderson, B. J., & Kritzer, M. F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00942 · Cited by 13 · see citing works

Sex differences in dopamine integrity and brain structure among healthy older adults: Relationships to episodic memory

Karalija, N., Papenberg, G., Wåhlin, A., Johansson, J. J., Andersson, M., Axelsson, J., Riklund, K., Lindenberger, U., Nyberg, L. H., & Bäckman, L. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.022 · Cited by 12 · see citing works

Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice

Pilski, A., & Graves, S. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713039 · Cited by 10 · see citing works

A sex difference in the onset of the latent learning impairment in rats

Stouffer, E. M., & Barry, J. L. (2013) · Developmental Psychobiology · doi:10.1002/dev.21168 · Cited by 8 · see citing works

Androgen effects on mesoprefrontal dopamine systems in the adult male brain

Kritzer, M. F., Adler, A., & Locklear, M. N. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.001 · Cited by 8 · see citing works

Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17β-estradiol in a murine model of Parkinson’s disease

Poirier, A.-A., Côté, M., Bourque, M., Jarras, H., Lamontagne‐Proulx, J., Morissette, M., Paolo, T. D., & Soulet, D. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.06.019 · Cited by 9 · see citing works

Differential vulnerability of locus coeruleus and dorsal raphe neurons to chronic methamphetamine-induced degeneration

Du, Y., Choi, S., Pilski, A., & Graves, S. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.949923 · Cited by 8 · see citing works

Seasonal variation in gonadal hormones, spatial cognition, and hippocampal attributes: More questions than answers

LaDage, L. D. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105151 · Cited by 6 · see citing works

Muscle function alterations in a Parkinson's disease animal model: Electromyographic recordings dataset

Albarracín, A. L., & Farfán, F. D. (2021) · Data in Brief · doi:10.1016/j.dib.2021.107712 · Cited by 6 · see citing works

6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females

de la Rosa, T., Sanabria, V., Gonçalves, V., Amado, D., & Scorza, F. A. (2021) · Clinics · doi:10.6061/clinics/2021/e3175 · Cited by 3 · see citing works

Role of Animal Models in Parkinson's Disease (PD): What Role They Play in Preclinical Translational Research

Srivastava, R., Dilnashin, H., Kapoor, D. U., Aparna, S., Heidarli, E., Singh, S. P., & Jain, V. K. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230223150347 · Cited by 4 · see citing works

Sexual dimorphism in the programming effects of prenatal manganese multi-media biomarker on temporal cognition in school-aged children

Lane, J. M., Liu, S. H., CORY-SLECHTA, D. A., Midya, V., Eggers, S. I., Alcala, C. S., Gil-Martínez, G., Rojo, M. M. T., & Wright, R. O. (2026) · Scientific Reports · doi:10.1038/s41598-026-44007-4 · Cited by 2 · see citing works

Respiratory deficits in a female rat model of Parkinson's disease

de la Rosa, T., Sanabria, V., Gonçalves, V., Ferreira, C. B., Cabral, L. M., Souza, F. D. C., Scerni, D. A., Scorza, F. A., Moreira, T. S., & Takakura, A. C. T. (2022) · Experimental Physiology · doi:10.1113/ep090378 · Cited by 2 · see citing works

The assessment of possible gender-related effect of endogenous striatal alpha-tocopherol level on MPTP neurotoxicity in mice

Nánási, N., Veres, G., Cseh, E. K., Martos, D., Hadady, L., Klivènyi, P., Vécsei, L., & Zádori, D. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04425 · Cited by 2 · see citing works

Tibolone Improves Motor Recovery and Regulates Neuroinflammation and Gliosis in a Model of Traumatic Spinal Cord Injury

Freyermuth-Trujillo, X., Sánchez‐Torres, S., Orozco-Barrios, C. E., Salgado‐Ceballos, H., Segura-Uribe, J. J., Guerra‐Araiza, C., León-Cholula, Á., Arrieta‐Cruz, I., Morán, J., & Coyoy-Salgado, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178327 · Cited by 1 · see citing works

Preservation of Extracellular and Tissue Dopamine During Tyrosine Hydroxylase Loss in Rat 6-OHDA Parkinson’s Model: Selective Compensation Restricted to Substantia Nigra

Galfano, A., McManus, R., Navarrete, W., Chaudhari, S., Bishop, C., & Salvatore, M. F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093923 · Cited by 1 · see citing works

Wykładniki ciśnienia tętniczego w chorobach zwyrodnieniowych układu nerwowego

Łukasz, W. (2014)

The bioanalytical assessment of brain alpha-tocopherol homeostasis in normal aging and in MPTP-induced neurotoxicity in mice

Nánási, N. (2021) · doi:10.14232/phd.10746

Moderate-intensity exercise as a preventive strategy against dopaminergic dysfunction in Long COVID: A mechanistic hypothesis

Hagiu, B.-A. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.111877

Cross-sectional associations between physical performance and sarcopenia risk in individuals with idiopathic Parkinson’s disease

Issa, R. A., Younis, G. A., Elsawy, N. A., Othman, G. A., El-Tawab, S. S., & ElkamsHoushy, A. A. (2026) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-026-00375-3

Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotype

Dumitrescu, A. M., Vest, M. F., Fleckenstein, A. E., Patterson, J. C., Ledbetter, C. R., Goeders, N. E., Loftis, J. M., Thompson, E., Lofton, K. T., & Murnane, K. S. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1773668

Genetic and epigenetic complexity of Parkinson’s disease: From dopamine pathways to estrogen interplay

Krishnan, D., Lakshman, N., Fenwick, E. A., Muthuswamy, K., & Sivasamy, R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.021

Systemic energy and neuroinflammatory disturbances in a lactacystin-induced rat model of Parkinson's disease

Khunderyakova, N. V., Pshenichnikova, T. V., Malkov, A., Булгин, И. В., Khmil, N. V., Medvedeva, V. P., Glushkova, O. V., Lunin, S. M., Parfenyuk, S. B., Khrenov, M. O., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116035

Astrocytic ATP13A2 modulates neuroinflammatory responses via mitochondrial fission in Parkinson’s disease

Qiao, C., Mo, H., Hu, X., Dang, T., Xu, F., Dan, Y., Ni, J., & Wang, L. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1959910

Neuroprotective actions of sex steroids in Parkinson’s disease

Bourque, M., Dluzen, D. E., & Paolo, T. D. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.014 · Cited by 239 · see citing works

Neuroprotection by Sex Steroid Hormones in Parkinson’s Disease (P3.068)

Smith, K. M., & Dahodwala, N. A. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.p3.068 · Cited by 1 · see citing works

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease

Al-Sweidi, S., Morissette, M., Bourque, M., & Paolo, T. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.031 · Cited by 40 · see citing works

Estrogen and SERM neuroprotection in animal models of Parkinson's disease

Morissette, M., Al-Sweidi, S., Callier, S., & Paolo, T. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.008 · Cited by 122 · see citing works

Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease

Al-Sweidi, S., Sánchez, M. G., Bourque, M., Morissette, M., Dluzen, D. E., & Paolo, T. D. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02193.x · Cited by 82 · see citing works